Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Forty-nine hospitalized patients with acute exacerbations of chronic bronchitis were randomly allocated a ten-day course of either pivmecillinam/pivampicillin or co-trimoxazole. Both treatments were equally effective clinically (pivmecillinam/pivampicillin successful in 72% of cases; co-trimoxazole ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1093/jac/14.2.179
データ提供:米国国立医学図書館(NLM)
Treating Acute Exacerbations of Chronic Bronchitis
This research delves into the world of chronic bronchitis, a condition as persistent as a desert wind. Researchers compared the effectiveness of pivmecillinam/pivampicillin and co-trimoxazole in treating acute exacerbations of chronic bronchitis in hospitalized patients. They found that both treatments were equally effective clinically, but pivmecillinam/pivampicillin had fewer side effects. It's like choosing the right camel for a long desert journey, ensuring a smooth ride with minimal discomfort.
Pivmecillinam/Pivampicillin: A Smoother Ride
This study explores the treatment options for acute exacerbations of chronic bronchitis. It's like choosing the right camel for a long desert journey, ensuring a smooth ride with minimal discomfort. The researchers found that pivmecillinam/pivampicillin and co-trimoxazole were equally effective in treating the condition, but pivmecillinam/pivampicillin had fewer side effects. This suggests that pivmecillinam/pivampicillin might be a more comfortable option for patients navigating this challenging journey.
Choosing the Right Camel
Chronic bronchitis is a persistent condition that can cause significant discomfort. This study provides valuable insights for choosing the right treatment, highlighting the benefits of pivmecillinam/pivampicillin in terms of its effectiveness and minimal side effects. It's like choosing a camel with a gentle gait and a sturdy pack saddle, ensuring a comfortable and efficient journey through the desert of illness.
Dr.Camel's Conclusion
This study explores the treatment options for acute exacerbations of chronic bronchitis. It's like choosing the right camel for a long desert journey, ensuring a smooth ride with minimal discomfort. The researchers found that pivmecillinam/pivampicillin and co-trimoxazole were equally effective in treating the condition, but pivmecillinam/pivampicillin had fewer side effects. This suggests that pivmecillinam/pivampicillin might be a more comfortable option for patients navigating this challenging journey.
Date :
- Date Completed 1984-12-28
- Date Revised 2019-05-11
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.